Medical Disclaimer and Research-Use-Only (RUO) Statement

This is the standing statement that governs the entire site and that the Regulatory status block on every compound and how-to page points back to. Read it as the frame around everything else we publish.

Not medical advice

Peptevity provides research and educational information only. It is not medical advice, and it is not a substitute for the judgment of a licensed physician or other qualified healthcare professional.

• We do not diagnose, treat, cure, prevent, or manage any disease or condition.
• We do not establish a clinician–patient relationship with any reader.
• We do not provide, and nothing on the site should be read as, dosing, prescribing, or self-administration instructions for any person. (See "No human dosing," below.)
• Decisions about your health, and about whether any compound is appropriate for you, belong with a licensed physician who knows your medical history. Never disregard or delay professional medical advice because of something you read here.

If you may be experiencing a medical emergency, contact your local emergency services immediately.

What "research use only" (RUO) means

Many of the compounds covered on Peptevity — including a substantial part of the healing, growth-hormone, longevity, and newer GLP-1 research-peptide catalog — are sold in the United States only as "research use only" (RUO) materials, commonly labeled "not for human consumption."

That label is a regulatory and legal status, and we explain it accurately rather than wink at evasion of it:

• RUO / "not for human consumption" means the material is intended for laboratory and research use, not for ingestion, injection, or any human use. It is not an FDA approval, not a quality assurance, and not a signal that human use is safe or legal.
• An RUO label does not mean a compound has been evaluated for human safety or efficacy. In most cases the opposite is true — the label exists precisely because the compound is not FDA-approved for human use.
• Buying, selling, or using RUO material outside its stated research purpose can carry legal and safety consequences that vary by jurisdiction. Peptevity does not facilitate, encourage, or instruct any such use.

We cover these compounds because readers are searching for them and deserve accurate, vendor-neutral, evidence-graded information — not because we endorse their use. Our editorial standards and sourcing policy keep that coverage honest.

FDA-approval status is stated on every page

Peptevity treats regulatory transparency as a core trust signal. Every compound and how-to page carries a standing, prominent Regulatory status block stating, with a date:

• whether the compound is FDA-approved for any human indication (and if so, which) — for example, semaglutide and tirzepatide are FDA-approved for specific indications under specific brand names;
• whether it is compounded, research-use-only, or not approved for any human use; and
• any relevant recall, advisory, or rulemaking status — including live 2026 items such as the 503A Category 2 review and the July 23–24, 2026 PCAC hearing.

We deliberately and repeatedly distinguish FDA-approved products from compounded versions and from research-grade material of the same molecule, because they carry different legal status and very different evidence and safety pictures. Conflating them is one of the most common — and most consequential — errors in this field. Regulatory facts are dated because they change; see our corrections policy for how updates are logged.

No human dosing or self-administration content — ever

This is a permanent editorial line. Peptevity does not publish human dosing protocols or instructions to inject, ingest, or otherwise self-administer any compound.

• Where dosing appears at all, it is a description of the research record — "in the cited trial, animals received X mg/kg" — presented to explain a study, never as guidance for a person.
• Reconstitution, storage, and reconstitution-calculator content is framed strictly as laboratory / research procedure. It explains the underlying chemistry and the math; it is not a how-to for preparing anything for human use, and it must not be read as one.

This is consistent with the RUO framing above: we will not provide the operational bridge between "research material not for human consumption" and "use in a person."

Compounds are not endorsed for human use

The presence of a compound on Peptevity is informational coverage, not an endorsement of its use. We describe what the research shows — graded by our evidence-grading methodology, with the animal-versus-human distinction made explicit — and we state the regulatory reality plainly. We make no claim that any covered compound is safe, effective, legal for you, or appropriate to use.

Frequently asked questions

Is the information on Peptevity medical advice? No. It is research and educational information only. We do not diagnose, treat, recommend, or provide dosing or self-administration instructions, and we do not replace a licensed physician. Health decisions, including whether any compound is appropriate for you, belong with your doctor.

What does "research use only" mean on a peptide? It is a regulatory status indicating the material is intended for laboratory research, not for human use, and is commonly labeled "not for human consumption." It is not an FDA approval and does not indicate the compound has been shown safe or effective in people — in most cases it reflects that the compound is not FDA-approved for human use at all.

Why won't Peptevity tell me how to dose or inject a peptide? Because doing so would be medical advice we do not give and, for unapproved or research-use-only compounds, an implicit endorsement of human use we explicitly do not make. We will describe what doses studies used, as a record of the research, but never as instructions for a person.

Does covering a compound mean Peptevity recommends it? No. We cover compounds people are researching so they can find accurate, vendor-neutral, evidence-graded information. Coverage is never an endorsement of use, and every page states the compound's regulatory status plainly.

Related editorial standards

• Editorial standards — the rules behind every page, including the no-dosing line.
• Evidence-grading methodology — why an evidence grade is never a green light.
• Sourcing and citation policy — the primary sources behind every regulatory claim.
• Conflict-of-interest and funding — why we sell nothing and link to no vendors.
• Corrections policy — how regulatory updates are dated and logged.
• The Peptevity Research Desk — authorship and the reserved reviewer slot.

External references: U.S. Food and Drug Administration, Health Canada, and DoD Operation Supplement Safety (OPSS) for regulatory and safety status.